BLOG

BioProcess Intl

Advances Toward Dry-Powder Formulations for Monoclonal Antibodies

We designed the TFF method to eliminate that problem. The technology generates millimeter-sized droplets that, because of their large size, minimize protein exposure to air–liquid interfaces. Thus, we have observed far less denaturation